Complete Filing Data
Arbutus Biopharma Corp reported Net Income Loss of -$33.50 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Arbutus Biopharma Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$33.5M | -$69.9M | -$72.8M | -$69.5M | -$76.2M | -$63.7M | -$153.7M | -$57.1M | -$84.4M | -$384.2M | -$62.7M | -$38.8M | -$14.1M | $29.6M | -$10.1M | -$12.4M | -$8.7M |
| Revenues | $14.1M | $6.2M | $18.1M | $39.0M | $11.0M | $6.9M | $6.0M | $5.9M | $10.7M | $1.5M | $23.3M | $15.0M | $15.5M | $14.1M | $16.8M | $21.4M | $14.4M |
| Operating Income Loss | -$38.2M | -$76.3M | -$78.1M | -$65.5M | -$73.5M | -$57.8M | -$143.9M | -$89.8M | -$110.9M | -$491.6M | -$103.9M | -$33.4M | -$12.2M | -$12.9M | -$10.7M | -$12.5M | -$8.5M |
| Research And Development Expense | $25.2M | $54.0M | $73.7M | $84.4M | $65.5M | $49.3M | $57.6M | $57.9M | $62.7M | $61.3M | $51.5M | $38.7M | $21.5M | $18.0M | $20.1M | $22.1M | $17.8M |
| Operating Expenses | $52.2M | $82.5M | $96.2M | $104.5M | $84.5M | $64.7M | $149.9M | $95.7M | $121.6M | $493.1M | $127.2M | $48.4M | $27.6M | $27.1M | $27.5M | $33.9M | $22.9M |
| General And Administrative Expense | $15.9M | $22.1M | $22.5M | $17.8M | $17.1M | $14.8M | $17.7M | $16.0M | $16.1M | $39.4M | $26.4M | $8.7M | $5.5M | $8.1M | $6.4M | $4.8M | $4.2M |
| Comprehensive Income Net Of Tax | -$33.5M | -$69.6M | -$70.8M | -$71.6M | -$76.4M | -$63.7M | -$153.8M | -$57.0M | -$84.4M | -$384.2M | -$88.6M | -$45.3M | -$17.2M | $30.1M | -$10.1M | ||
| Nonoperating Income Expense | $4.7M | $6.4M | $5.3M | $444.0K | -$2.7M | -$5.9M | -$22.5M | $28.4M | $2.2M | $2.5M | $25.0M | -$5.4M | -$1.9M | ||||
| Interest Expense | $459.0K | $1.7M | $2.9M | $4.0M | $2.1M | $226.0K | $261.0K | $0.00 | $0.00 | ||||||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $4.4M | $0.00 | $0.00 | -$12.7M | -$4.3M | -$24.3M | -$105.0M | -$16.2M | $0.00 | $0.00 | |||||
| Net Income Loss Available To Common Stockholders Basic | -$69.5M | -$88.4M | -$75.9M | -$164.9M | -$67.2M | -$85.3M | -$384.2M | -$62.7M | |||||||||
| Restructuring Charges | $12.9M | $3.7M | $0.00 | $0.00 | $64.0K | $156.0K | $4.8M | $0.00 | |||||||||
| Deferred Revenue Current | $0.00 | $7.6M | $11.8M | $16.5M | $0.00 | $15.0K | $868.0K | $5.8M | $3.5M | $3.1M | $2.8M | $2.0M | |||||
| Licenses Revenue | $10.0M | $1.3M | $11.6M | $3.2M | $5.0M | $2.0M | $500.0K | $514.1K | $596.5K | ||||||||
| Contracts Revenue | $682.0K | $229.0K | $11.7M | $11.7M | $10.4M | $12.1M | $16.3M | $14.9M | $13.8M | ||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$59.0K | $15.0K | $0.00 | $0.00 | -$25.9M | -$6.5M | -$3.1M | $474.0K | -$53.1K | ||||||||
| Deferred Revenue Noncurrent | $0.00 | $2.9M | $0.00 | $6.0M | $0.00 | $0.00 | $0.00 | $213.0K | $9.9M | $722.4K | $1.7M | $2.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$7.7M | $2.5M | -$24.5M | -$19.7M | -$19.8M | -$17.9M | -$20.1M | -$17.1M | -$16.3M | -$17.6M | -$14.2M | -$15.8M | -$19.2M | -$19.4M | -$16.4M | -$18.8M | -$14.1M | -$13.9M | -$24.7M | -$82.5M | -$23.3M | -$23.3M | -$18.2M | -$24.5M | $3.1M | -$17.4M | -$35.9M | -$11.6M | -$18.3M | -$18.6M | -$218.7M | -$19.6M | -$130.0M | -$15.9M | -$5.3M | -$29.0M | -$14.9M | -$12.0M | -$6.2M | -$8.6M | -$6.1M | -$18.0M | -$2.6M | -$5.9M | -$3.0M | -$2.5M |
| Revenues | $529.0K | $10.7M | $1.8M | $1.3M | $1.7M | $1.5M | $4.7M | $4.7M | $6.7M | $6.0M | $14.2M | $12.6M | $3.3M | $2.3M | $2.1M | $1.5M | $1.5M | $1.5M | $1.6M | $3.1M | $653.0K | $679.0K | $1.7M | $1.6M | $1.2M | $1.4M | $2.5M | $6.9M | $1.0M | $235.0K | -$195.0K | $774.0K | $309.0K | $603.0K | $12.7M | $4.1M | $3.4M | $4.7M | $4.4M | $4.4M | $1.8M | $4.4M | $752.0K | $3.0M | $2.8M | $2.1M |
| Operating Income Loss | -$8.7M | $1.5M | -$25.7M | -$21.4M | -$21.6M | -$19.4M | -$21.6M | -$18.4M | -$17.4M | -$17.8M | -$14.1M | -$11.0M | -$18.4M | -$18.6M | -$15.7M | -$15.2M | -$13.1M | -$13.1M | -$13.1M | -$91.0M | -$20.6M | -$19.2M | -$16.9M | -$32.4M | -$22.0M | -$18.4M | -$60.2M | -$12.9M | -$19.5M | -$18.3M | -$257.4M | -$19.0M | -$195.2M | -$20.0M | -$11.8M | -$58.1M | -$14.4M | -$18.0M | -$10.7M | -$6.8M | -$9.4M | -$6.0M | -$2.4M | -$3.7M | -$3.1M | -$3.0M |
| Research And Development Expense | $5.8M | $5.5M | $9.0M | $14.3M | $15.6M | $15.4M | $20.2M | $17.7M | $18.3M | $20.1M | $22.9M | $18.5M | $16.7M | $15.8M | $13.8M | $12.1M | $10.5M | $10.4M | $17.7M | $12.7M | $14.7M | $16.6M | $16.4M | $13.9M | $15.5M | $15.4M | $13.9M | $15.7M | $15.2M | $13.1M | $16.4M | $9.7M | $10.6M | $9.3M | $9.3M | $8.2M | $5.5M | $4.9M | $4.1M | |||||||
| Operating Expenses | $9.2M | $9.3M | $27.5M | $22.8M | $23.3M | $20.9M | $26.2M | $23.0M | $24.1M | $23.8M | $28.4M | $23.6M | $21.7M | $21.0M | $17.8M | $16.7M | $14.7M | $14.6M | $94.1M | $21.3M | $19.9M | $34.0M | $23.3M | $19.8M | $19.8M | $20.5M | $18.5M | $19.7M | $195.6M | $20.6M | $62.2M | $17.9M | $22.7M | $11.2M | $11.2M | $10.4M | $6.6M | $5.9M | $5.1M | |||||||
| General And Administrative Expense | $3.0M | $3.3M | $5.8M | $4.5M | $7.5M | $5.3M | $5.8M | $6.0M | $5.6M | $3.5M | $5.2M | $4.9M | $4.2M | $4.5M | $3.9M | $4.1M | $3.6M | $3.6M | $3.2M | $8.2M | $4.4M | $2.6M | $3.8M | $3.7M | $3.7M | $4.6M | $4.3M | $3.7M | $23.8M | $7.2M | $7.7M | $7.7M | $2.7M | $1.8M | $1.8M | $2.1M | $960.0K | $849.0K | $893.0K | |||||||
| Comprehensive Income Net Of Tax | -$7.7M | $2.5M | -$24.6M | -$19.5M | -$19.7M | -$17.8M | -$19.5M | -$16.9M | -$15.5M | -$18.5M | -$14.9M | -$16.8M | -$19.2M | -$19.4M | -$16.4M | -$18.8M | -$14.0M | -$13.6M | -$82.5M | -$23.4M | -$23.3M | -$24.5M | $3.1M | -$17.4M | -$11.6M | -$19.6M | -$130.0M | -$15.9M | -$39.1M | -$11.7M | -$21.2M | -$13.4M | -$2.3M | -$20.1M | -$5.2M | -$4.3M | -$3.4M | |||||||||
| Nonoperating Income Expense | $917.0K | $1.0M | $1.2M | $1.7M | $1.8M | $1.5M | $1.5M | $1.3M | $1.1M | $244.0K | -$83.0K | -$347.0K | -$750.0K | -$745.0K | -$705.0K | -$3.5M | -$946.0K | -$714.0K | -$4.1M | -$2.7M | -$4.1M | $3.7M | $25.1M | $976.0K | $1.3M | $1.2M | -$328.0K | -$620.0K | $384.0K | $4.1M | $14.0M | -$466.0K | $6.0M | -$1.8M | ||||||||||||
| Interest Expense | $34.0K | $44.0K | $46.0K | $171.0K | $198.0K | $429.0K | $482.0K | $506.0K | $762.0K | $763.0K | $772.0K | $1.1M | $1.1M | $1.0M | $1.1M | $2.0K | $12.0K | $0.00 | $0.00 | $104.0K | $76.0K | $68.0K | $42.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.4M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$12.7M | $0.00 | $0.00 | -$4.3M | $0.00 | $0.00 | $0.00 | -$64.9M | -$15.2M | $0.00 | $0.00 | |||||||||||||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$17.6M | -$14.2M | -$15.8M | -$24.2M | -$22.7M | -$19.6M | -$21.8M | -$17.1M | -$16.8M | -$27.5M | -$85.3M | -$26.1M | -$26.0M | -$20.9M | -$27.0M | $550.0K | -$19.8M | -$36.8M | -$11.6M | -$18.3M | -$18.6M | |||||||||||||||||||||||||
| Restructuring Charges | $98.0K | $12.4M | $12.4M | $3.6M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $7.0K | $57.0K | $182.0K | -$266.0K | $117.0K | -$492.0K | $2.6M | $1.6M | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||
| Deferred Revenue Current | $0.00 | $0.00 | $6.8M | $10.9M | $11.0M | $11.5M | $12.1M | $15.3M | $15.1M | $14.9M | $17.0M | $23.3M | $1.7M | $2.7M | $15.0K | $2.6M | $2.6M | $15.0K | $711.0K | $924.0K | $4.8M | $5.6M | $5.2M | $4.9M | $6.0M | $5.6M | ||||||||||||||||||||
| Licenses Revenue | $721.0K | $217.0K | $687.0K | $277.0K | $496.0K | $1.0M | $1.1M | $1.2M | $784.0K | $667.0K | $741.0K | $2.0K | $5.0M | |||||||||||||||||||||||||||||||||
| Contracts Revenue | $318.0K | $18.0K | $87.0K | $32.0K | $107.0K | $3.0M | $2.3M | $3.5M | $3.6M | $1.1M | $3.7M | $3.0M | $2.8M | $2.1M | ||||||||||||||||||||||||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $0.00 | $0.00 | -$52.0K | -$22.0K | $0.00 | $0.00 | $0.00 | -$10.1M | $3.2M | -$9.2M | -$4.8M | $3.8M | -$2.2M | $710.0K | -$1.2M | -$876.0K | ||||||||||||||||||||||||||||||
| Deferred Revenue Noncurrent | $0.00 | $0.00 | $2.9M | $0.00 | $0.00 | $3.3M | $10.6M | $10.8M | $15.6M | $4.1M | $4.8M | $0.00 | $0.00 | $0.00 | $6.9M | $8.0M | $7.9M | $10.1M | $10.5M | $10.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $76.6M | $97.4M | $106.0M | $136.9M | $169.4M | $102.0M | $72.7M | $200.2M | $182.5M | $203.0M | $547.7M | $88.0M | $59.2M | $40.9M | $5.2M | $10.8M | $22.5M | $30.9M |
| Cash And Cash Equivalents At Carrying Value | $18.0M | $36.3M | $26.3M | $30.8M | $109.3M | $52.3M | $31.8M | $36.9M | $54.3M | $23.4M | $166.8M | $72.2M | $68.7M | $47.0M | $9.0M | $12.4M | $24.4M | $26.2M |
| Business Combination Contingent Consideration Liability Noncurrent | $8.4M | $10.2M | $7.6M | $7.5M | $5.3M | $3.4M | $3.0M | $3.1M | $10.4M | $9.1M | $7.5M | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $18.0M | $36.3M | $26.3M | $30.8M | $109.3M | $52.3M | $31.8M | $36.9M | ||||||||||
| Retained Earnings Accumulated Deficit | -$1.38B | -$1.35B | -$1.28B | -$1.20B | -$1.13B | -$1.05B | -$970.1M | -$805.2M | -$738.1M | -$652.7M | -$267.0M | -$205.9M | -$167.0M | -$153.0M | -$258.8M | -$248.9M | ||
| Property Plant And Equipment Net | $32.0K | $3.3M | $4.7M | $5.1M | $6.0M | $6.9M | $8.7M | $10.1M | $12.2M | $6.9M | $3.2M | $1.8M | $1.4M | $1.4M | $2.2M | $3.1M | ||
| Prepaid Expense And Other Assets Current | $1.5M | $2.3M | $4.2M | $2.9M | $4.4M | $3.1M | $1.8M | $3.2M | $2.1M | $1.3M | $1.2M | $1.7M | $1.1M | $329.3K | $424.4K | $315.1K | ||
| Liabilities Current | $6.0M | $15.6M | $22.5M | $32.9M | $11.2M | $9.5M | $7.8M | $11.2M | $14.6M | $10.6M | $10.6M | $20.2M | $12.5M | $11.0M | $7.0M | $8.1M | ||
| Liabilities And Stockholders Equity | $94.6M | $131.7M | $144.4M | $195.4M | $204.5M | $137.1M | $105.5M | $227.9M | $237.2M | $275.9M | $712.3M | $118.2M | $71.7M | $52.6M | $14.0M | $21.0M | ||
| Liabilities | $18.0M | $34.3M | $38.4M | $58.6M | $35.0M | $35.1M | $32.8M | $27.7M | $54.7M | $72.9M | $164.6M | $30.1M | $12.5M | $11.7M | $8.7M | $10.3M | ||
| Common Stock Value | $1.42B | $1.41B | $1.35B | $1.32B | $1.29B | $985.9M | $898.5M | $879.4M | $876.1M | $867.4M | $834.2M | $290.0M | $216.7M | $181.8M | $233.5M | $229.5M | ||
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | -$1.8M | $2.6M | $69.0K | $2.2M | $1.9M | $473.0K | -$173.0K | -$7.3M | $1.4M | $1.6M | $770.0K | $0.00 | $0.00 | |||||
| Assets Current | $94.5M | $127.3M | $132.0M | $151.1M | $160.7M | $127.7M | $93.8M | $129.2M | $129.4M | $132.6M | $183.9M | $116.4M | $70.3M | $51.2M | $11.8M | $17.9M | ||
| Assets | $94.6M | $131.7M | $144.4M | $195.4M | $204.5M | $137.1M | $105.5M | $227.9M | $237.2M | $275.9M | $712.3M | $118.2M | $71.7M | $52.6M | $14.0M | $21.0M | ||
| Accounts Receivable Net Current | $1.4M | $2.4M | $1.8M | $1.4M | $899.0K | $1.3M | $1.2M | $1.4M | $402.0K | $273.0K | $1.0M | $1.9M | $117.0K | $1.1M | $880.7K | $3.3M | ||
| Accounts Payable And Accrued Liabilities Current | $5.5M | $7.6M | $10.3M | $16.0M | $10.8M | $9.2M | $7.2M | $9.4M | $10.6M | $9.9M | $8.8M | $9.3M | $3.7M | $3.8M | $4.0M | $6.2M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$48.1M | -$48.1M | -$48.4M | -$50.5M | -$48.3M | -$48.2M | -$48.2M | -$48.2M | -$48.2M | -$48.2M | -$49.8M | -$22.3M | -$15.8M | -$12.7M | ||||
| Liability Related To Sale Of Future Royalties Noncurrent | $3.4M | $4.8M | $7.0M | $10.4M | $16.3M | $19.6M | $19.0M | $0.00 | ||||||||||
| Adjustmentsto Additional Paidin Capital Certain Fair Value Adjustmentsto Liability Stock Option Awards | $26.0K | $263.0K | $18.0K | $180.0K | $472.0K | -$540.0K | $3.6M | |||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$5.1M | -$17.4M | $30.9M | -$143.4M | $94.6M | $3.5M | $21.7M | $38.0M | -$3.4M | -$12.1M | -$1.8M | |||||||
| Debt Securities Available For Sale Unrealized Gain Loss | -$2.2M | -$164.0K | $14.0K | $0.00 | ||||||||||||||
| Preferred Stock Dividends And Other Adjustments | $0.00 | $12.1M | $12.1M | $11.1M | $10.1M | $911.0K | $0.00 | $0.00 | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$18.3M | $10.0M | -$4.5M | -$78.5M | $57.0M | $20.5M | -$5.1M | |||||||||||
| Operating Lease Right Of Use Asset | $0.00 | $1.0M | $1.4M | $1.7M | $2.1M | $2.4M | $2.7M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $77.4M | $83.0M | $79.2M | $106.9M | $122.5M | $114.6M | $119.3M | $134.7M | $143.9M | $145.5M | $153.1M | $165.8M | $130.1M | $100.8M | $114.1M | $97.3M | $65.5M | $73.3M | $83.6M | $164.5M | $181.2M | $215.3M | $238.1M | $232.4M | $167.4M | $175.8M | $189.1M | $416.6M | $431.3M | $538.1M | $553.8M | $588.5M | $593.7M | $95.5M | $105.1M | $105.5M | ||||||
| Cash And Cash Equivalents At Carrying Value | $22.4M | $37.4M | $37.1M | $31.8M | $62.8M | $43.1M | $17.5M | $27.2M | $40.6M | $24.0M | $47.3M | $81.3M | $77.9M | $31.0M | $79.4M | $96.9M | $45.9M | $26.4M | $90.1M | $78.9M | $84.0M | $21.9M | $10.2M | $12.5M | $15.2M | $24.2M | $29.9M | $26.6M | $43.0M | $144.8M | $181.1M | $207.2M | $232.3M | $78.2M | $85.3M | $134.4M | $35.8M | $35.8M | $38.7M | |||
| Business Combination Contingent Consideration Liability Noncurrent | $11.1M | $10.8M | $10.5M | $8.3M | $8.0M | $7.8M | $7.4M | $7.2M | $7.8M | $5.9M | $5.7M | $3.6M | $5.1M | $4.2M | $3.6M | $3.3M | $3.2M | $3.1M | $3.0M | $3.4M | $3.3M | $4.2M | $9.8M | $9.6M | $10.2M | $10.0M | $10.1M | $8.3M | $8.0M | $7.7M | $6.7M | $5.1M | $4.7M | $4.7M | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $22.4M | $37.4M | $37.1M | $31.8M | $62.8M | $43.1M | $17.5M | $27.2M | $40.6M | $24.0M | $47.3M | $81.3M | $77.9M | $31.0M | $79.4M | $96.9M | $45.9M | $26.4M | $90.1M | $78.9M | $84.0M | $21.9M | $10.2M | $12.5M | $66.9M | $15.2M | $24.2M | $23.4M | ||||||||||||||
| Retained Earnings Accumulated Deficit | -$1.38B | -$1.37B | -$1.37B | -$1.33B | -$1.31B | -$1.29B | -$1.26B | -$1.24B | -$1.22B | -$1.18B | -$1.16B | -$1.15B | -$1.11B | -$1.09B | -$1.07B | -$1.03B | -$1.00B | -$986.9M | -$942.6M | -$857.3M | -$831.2M | -$784.3M | -$757.3M | -$757.8M | -$699.6M | -$688.0M | -$669.8M | -$432.5M | -$412.9M | -$282.9M | -$261.7M | -$232.7M | -$217.9M | -$199.7M | -$191.1M | -$185.0M | ||||||
| Property Plant And Equipment Net | $137.0K | $148.0K | $168.0K | $3.6M | $4.1M | $4.4M | $5.0M | $5.4M | $4.9M | $5.2M | $5.5M | $5.7M | $6.4M | $6.8M | $6.6M | $7.3M | $7.7M | $8.2M | $9.2M | $9.4M | $9.7M | $10.4M | $10.7M | $11.8M | $12.6M | $12.7M | $11.5M | $4.1M | $3.9M | $3.2M | $2.3M | $2.0M | $1.8M | $1.6M | $1.7M | $1.5M | ||||||
| Prepaid Expense And Other Assets Current | $2.8M | $4.0M | $2.9M | $3.4M | $4.5M | $4.5M | $5.3M | $3.7M | $3.5M | $4.6M | $5.6M | $5.9M | $3.5M | $3.8M | $4.1M | $1.9M | $2.0M | $2.4M | $1.8M | $2.8M | $682.0K | $1.1M | $1.2M | $1.5M | $1.5M | $1.6M | $1.6M | $1.5M | $2.0M | $1.5M | $1.2M | $1.8M | $1.3M | $696.0K | $335.0K | $561.0K | ||||||
| Liabilities Current | $5.2M | $5.0M | $19.4M | $18.9M | $22.6M | $20.3M | $22.3M | $24.5M | $25.2M | $27.5M | $29.8M | $32.4M | $10.1M | $8.8M | $6.7M | $7.6M | $6.3M | $4.0M | $8.8M | $8.8M | $8.8M | $12.7M | $11.5M | $10.4M | $8.2M | $11.9M | $10.9M | $8.4M | $10.1M | $11.1M | $13.8M | $16.1M | $24.9M | $19.5M | $16.4M | $23.0M | ||||||
| Liabilities And Stockholders Equity | $97.7M | $103.3M | $117.0M | $140.4M | $160.0M | $150.3M | $158.6M | $176.8M | $191.2M | $203.8M | $215.8M | $236.9M | $165.6M | $135.4M | $146.2M | $131.1M | $97.6M | $102.6M | $117.3M | $192.6M | $209.2M | $245.4M | $277.0M | $270.0M | $239.8M | $255.1M | $268.1M | $514.7M | $530.9M | $703.3M | $722.6M | $773.8M | $787.1M | $125.1M | $132.1M | $138.5M | ||||||
| Liabilities | $20.3M | $20.3M | $37.9M | $33.6M | $37.6M | $35.7M | $39.3M | $42.1M | $47.3M | $58.3M | $62.7M | $71.0M | $35.5M | $34.5M | $32.1M | $33.8M | $32.1M | $29.4M | $33.6M | $28.1M | $28.0M | $30.1M | $38.9M | $37.6M | $72.5M | $79.3M | $79.0M | $98.1M | $99.5M | $165.2M | $168.8M | $185.3M | $193.4M | $29.6M | $26.9M | $33.0M | ||||||
| Common Stock Value | $1.42B | $1.42B | $1.42B | $1.41B | $1.40B | $1.38B | $1.35B | $1.34B | $1.34B | $1.31B | $1.30B | $1.30B | $1.07B | $1.02B | $1.01B | $965.4M | $916.1M | $911.1M | $884.6M | $884.6M | $882.1M | $878.8M | $878.2M | $876.3M | $876.0M | $873.8M | $870.8M | $864.4M | $861.1M | $840.5M | $828.6M | $821.7M | $814.4M | $288.4M | $284.8M | $283.6M | ||||||
| Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 | $299.0K | $180.0K | $273.0K | $201.0K | $129.0K | $112.0K | -$376.0K | $130.0K | $125.0K | -$5.6M | $193.0K | -$848.0K | $197.0K | -$110.0K | $1.1M | $260.0K | $252.0K | $244.0K | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||
| Assets Current | $97.4M | $103.1M | $116.8M | $132.8M | $148.2M | $135.9M | $141.6M | $158.8M | $152.9M | $141.1M | $157.8M | $172.7M | $126.5M | $83.5M | $137.3M | $121.2M | $85.5M | $88.3M | $94.3M | $99.6M | $112.5M | $144.0M | $157.8M | $175.2M | $90.8M | $105.9M | $120.3M | $151.8M | $168.1M | $174.8M | $200.0M | $215.7M | $239.8M | $111.7M | $118.2M | $137.0M | ||||||
| Assets | $97.7M | $103.3M | $117.0M | $140.4M | $160.0M | $150.3M | $158.6M | $176.8M | $191.2M | $203.8M | $215.8M | $236.9M | $165.6M | $135.4M | $146.2M | $131.1M | $97.6M | $102.6M | $117.3M | $192.6M | $209.2M | $245.4M | $277.0M | $270.0M | $239.8M | $255.1M | $268.1M | $514.7M | $530.9M | $703.3M | $722.6M | $773.8M | $787.1M | $125.1M | $132.1M | $138.5M | ||||||
| Accounts Receivable Net Current | $905.0K | $1.0M | $1.2M | $1.6M | $1.8M | $2.1M | $2.2M | $2.6M | $2.7M | $1.8M | $2.0M | $1.3M | $1.7M | $1.3M | $1.3M | $1.1M | $1.1M | $1.1M | $2.5M | $1.5M | $923.0K | $538.0K | $1.3M | $719.0K | $846.0K | $1.0M | $7.9M | $395.0K | $456.0K | $340.0K | $2.2M | $6.3M | $4.6M | $2.1M | $299.0K | $1.5M | ||||||
| Accounts Payable And Accrued Liabilities Current | $4.7M | $4.5M | $12.1M | $7.5M | $11.1M | $8.2M | $9.8M | $8.8M | $9.7M | $12.3M | $12.5M | $8.7M | $9.7M | $8.4M | $6.1M | $6.9M | $5.8M | $3.6M | $8.2M | $7.9M | $6.8M | $8.5M | $7.4M | $6.5M | $6.4M | $8.3M | $7.4M | $7.1M | $7.8M | $7.7M | $7.5M | $6.9M | $14.0M | $5.9M | $3.8M | $4.6M | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$48.1M | -$48.2M | -$48.2M | -$48.1M | -$48.3M | -$48.4M | -$48.9M | -$49.5M | -$49.6M | -$51.0M | -$50.1M | -$49.4M | -$48.2M | -$48.2M | -$48.2M | -$48.1M | -$48.1M | -$48.0M | -$48.2M | -$48.2M | -$48.2M | -$48.2M | -$48.2M | -$48.2M | -$49.8M | -$49.8M | -$49.8M | -$49.8M | -$49.8M | -$49.8M | -$41.6M | -$28.3M | -$31.5M | -$19.0M | -$14.2M | -$18.0M | ||||||
| Liability Related To Sale Of Future Royalties Noncurrent | $3.7M | $3.9M | $4.4M | $5.3M | $5.9M | $6.4M | $8.1M | $8.8M | $9.4M | $12.3M | $14.2M | $15.4M | $17.9M | $19.0M | $19.4M | $20.1M | $19.7M | $19.4M | $18.7M | |||||||||||||||||||||||
| Adjustmentsto Additional Paidin Capital Certain Fair Value Adjustmentsto Liability Stock Option Awards | $2.0K | $3.0K | $21.0K | -$44.0K | $51.0K | $40.0K | -$137.0K | -$92.0K | $180.0K | $55.0K | $230.0K | $47.0K | -$407.0K | -$34.0K | -$504.0K | -$190.0K | ||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$2.3M | -$41.8M | -$9.0M | -$5.6M | $6.4M | -$16.3M | -$101.8M | -$22.0M | -$26.1M | -$25.1M | $160.1M | -$7.1M | -$49.1M | $65.6M | -$2.9M | -$3.9M | ||||||||||||||||||||||||||
| Debt Securities Available For Sale Unrealized Gain Loss | $58.0K | -$21.0K | -$31.0K | $218.0K | $63.0K | $50.0K | $584.0K | $166.0K | $854.0K | -$907.0K | -$691.0K | -$1.1M | -$31.0K | -$31.0K | $3.0K | -$72.0K | $122.0K | $251.0K | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||
| Preferred Stock Dividends And Other Adjustments | $0.00 | $0.00 | $0.00 | $5.1M | $3.3M | $3.2M | $3.0M | $3.0M | $3.0M | $2.8M | $2.8M | $2.7M | $2.6M | $2.5M | $2.3M | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $746.0K | $16.8M | $9.8M | -$28.0M | $27.2M | -$5.4M | $11.2M | -$5.1M | $47.0M | $11.7M | -$2.3M | -$41.8M | -$9.0M | |||||||||||||||||||||||||||||
| Operating Lease Right Of Use Asset | $0.00 | $0.00 | $0.00 | $1.1M | $1.2M | $1.3M | $1.5M | $1.6M | $1.7M | $1.8M | $1.9M | $2.0M | $2.2M | $2.2M | $2.3M | $2.5M | $2.6M | $2.7M | $2.8M | $2.9M | $3.1M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Stock Options Exercised | $5.5M | $7.5M | $260.0K | $122.0K | $2.1M | $449.0K | $307.0K | $1.4M | $100.0K | $192.0K | $1.7M | $2.6M | $389.0K | $71.0K | $10.8K | $34.9K | $7.9K |
| Payments To Acquire Property Plant And Equipment | $0.00 | $182.0K | $1.0M | $512.0K | $809.0K | $229.0K | $589.0K | $1.1M | $7.3M | $4.0M | $2.3M | $1.1M | $725.0K | $15.0K | $60.4K | $830.9K | $1.7M |
| Net Cash Provided By Used In Operating Activities | -$39.6M | -$64.9M | -$85.9M | -$35.4M | -$67.5M | -$51.4M | -$71.0M | -$67.9M | -$48.6M | -$57.9M | -$56.4M | -$12.4M | -$6.7M | $32.9M | -$7.8M | -$11.2M | -$5.5M |
| Net Cash Provided By Used In Investing Activities | $15.6M | $22.9M | $50.8M | -$74.9M | -$12.7M | -$14.9M | $28.3M | -$4.1M | $27.8M | -$99.1M | $7.7M | -$43.0M | -$725.0K | -$12.0K | -$60.4K | -$830.9K | $4.0M |
| Net Cash Provided By Used In Financing Activities | $5.7M | $52.0M | $30.6M | $31.8M | $137.2M | $86.7M | $37.5M | $55.6M | $49.3M | $12.6M | $143.9M | $60.7M | $32.7M | $4.5M | $4.6M | $34.9K | $7.9K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.7M | -$2.3M | $943.0K | -$2.4M | $1.0M | $752.0K | -$1.6M | $648.0K | $833.0K | $115.0K | -$159.0K | $773.0K | $776.0K | -$97.0K | $107.5K | $88.1K | $126.6K |
| Increase Decrease In Accounts Receivable | -$1.4M | $633.0K | $424.0K | $453.0K | -$413.0K | $108.0K | -$227.0K | $1.0M | $129.0K | -$735.0K | -$628.0K | $1.9M | -$889.0K | $190.0K | -$2.4M | $2.3M | $420.5K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$2.1M | -$2.7M | -$5.8M | $5.2M | $1.9M | $1.7M | -$3.3M | -$1.3M | $736.0K | $26.0K | -$2.5M | $6.3M | $130.0K | -$197.0K | -$2.1M | $498.1K | $1.2M |
| Increase Decrease In Fair Value Of Contingent Consideration Liability | -$173.0K | -$7.3M | $1.4M | $1.6M | $770.0K | $0.00 | $0.00 | ||||||||||
| Proceeds From Issuance Of Common Stock | $134.7M | $86.3M | $18.6M | $0.00 | $0.00 | $0.00 | $142.2M | $56.5M | $32.0M | $3.8M | $4.6M | ||||||
| Increase Decrease In Deferred Revenue | -$10.4M | -$1.4M | -$10.7M | $22.5M | $0.00 | $2.7M | -$1.1M | -$13.1M | $13.2M | -$153.0K | -$655.0K | $354.7K | $3.0M | $703.3K | |||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | $12.7M | $10.7M | $9.7M | $11.2M | $11.7M | $11.8M | $16.5M | $15.6M | |||||||||
| Share Based Compensation | $7.0M | $9.0M | $9.3M | $7.2M | $6.4M | $6.2M | $6.8M | $6.2M | $15.1M | $903.0K | $982.3K | $633.4K | $650.6K | $265.7K | |||
| Effect Of Exchange Rate On Cash And Cash Equivalents | $68.0K | -$1.0M | $2.4M | $1.0M | -$578.0K | -$1.8M | -$3.6M | $550.0K | -$100.2K | -$7.2K | -$325.7K | ||||||
| Proceeds From Warrant Exercises | $0.00 | $353.0K | $445.0K | $42.0K | $1.6M | $289.0K | $632.0K | ||||||||||
| Proceeds From Sale Of Property Plant And Equipment | $364.0K | $0.00 | $20.0K | $0.00 | $0.00 | $11.0K | $25.0K | $3.0K | $25.0K | $0.00 | $80.0K | $0.00 | $3.0K | ||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $14.0K | -$49.0K | $25.0K | -$22.0K | $5.0K | $56.0K | $68.0K | ||||||||||
| Payments For Proceeds From Investments | $3.0M | -$35.1M | $82.6M | -$9.6M | $42.0M | $0.00 | |||||||||||
| Increase Decrease In Other Operating Liabilities | -$557.0K | -$430.0K | -$444.0K | -$405.0K | -$374.0K | -$375.0K | -$744.0K | $0.00 | |||||||||
| Increase Decrease In Income Taxes Receivable | $0.00 | $49.0K | $47.0K | $47.0K | $188.0K | $52.0K | $31.0K | -$323.0K | -$71.3K | $123.4K | -$124.3K | ||||||
| Proceeds From Income Tax Refunds | $0.00 | $108.0K | $0.00 | $24.0K | $0.00 | $10.0K | $323.0K | $103.7K | $36.6K | $276.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q2 2013 | Q1 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Stock Options Exercised | $2.7M | $2.5M | $259.0K | $8.0K | $208.0K | $166.0K | $0.00 | $2.0K | $288.0K | $435.0K | $735.0K | $103.0K | $61.0K | $4.0K | $1.0K | $76.0K | $1.0K | $115.0K | $116.0K | $939.0K | $620.0K | $268.0K | $148.0K | $1.9M | $22.0K | $82.0K | |||||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $95.0K | $117.0K | $75.0K | $99.0K | $0.00 | $255.0K | $240.0K | $31.0K | $237.0K | $425.0K | $248.0K | $538.0K | $3.1M | $3.4M | $168.0K | $954.0K | $276.0K | $589.0K | $383.0K | $141.0K | $152.0K | $246.0K | $335.0K | $120.0K | $201.0K | |||||||||||||||||||
| Net Cash Provided By Used In Operating Activities | -$13.4M | -$19.3M | -$27.3M | $20.6M | -$17.9M | -$15.5M | -$23.5M | -$17.6M | -$16.6M | -$13.2M | -$17.6M | -$20.0M | -$15.7M | -$5.1M | -$17.5M | -$14.7M | -$16.8M | -$11.5M | -$2.5M | -$16.7M | -$17.8M | -$6.7M | -$8.0M | $9.2M | -$3.7M | -$2.8M | |||||||||||||||||||
| Net Cash Provided By Used In Investing Activities | $11.3M | $11.7M | $16.7M | -$60.1M | $18.2M | -$2.4M | $16.2M | $10.0M | $61.0M | $24.4M | $15.0M | -$75.7M | $5.3M | -$1.4M | $23.2M | -$880.0K | -$85.4M | -$13.6M | -$17.7M | -$10.3M | $37.5M | -$443.0K | -$43.2M | -$335.0K | -$120.0K | -$201.0K | |||||||||||||||||||
| Net Cash Provided By Used In Financing Activities | $2.8M | $24.4M | $20.4M | $11.5M | $26.9M | $12.5M | $18.5M | $2.5M | $2.5M | $435.0K | $735.0K | $54.4M | $61.0K | $4.0K | $354.0K | $76.0K | $446.0K | $115.0K | $116.0K | $960.0K | $142.8M | $684.0K | $234.0K | $59.3M | $76.0K | $138.0K | |||||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$413.0K | $156.0K | $468.0K | $1.5M | $857.0K | $439.0K | -$1.1M | $1.6M | -$2.3M | -$109.0K | -$222.0K | -$687.0K | -$83.0K | $9.0K | $264.0K | -$584.0K | $573.0K | $273.0K | -$469.0K | $519.0K | -$221.0K | $383.0K | -$243.0K | -$482.0K | $47.0K | $494.0K | |||||||||||||||||||
| Increase Decrease In Accounts Receivable | -$1.2M | $363.0K | $1.3M | $414.0K | -$47.0K | -$132.0K | $957.0K | $608.0K | -$777.0K | -$784.0K | $603.0K | $317.0K | -$196.0K | -$6.7M | $7.6M | -$61.0K | $116.0K | -$668.0K | -$4.0M | $1.7M | $2.9M | $1.9M | -$1.2M | $1.4M | $2.3M | $417.0K | |||||||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $4.5M | -$2.0M | -$6.4M | -$2.1M | -$2.8M | -$3.6M | $538.0K | $888.0K | -$2.9M | $1.1M | $921.0K | -$4.2M | -$1.8M | $2.2M | -$3.9M | -$887.0K | $42.0K | -$1.1M | $2.4M | -$7.4M | $2.0M | $2.4M | -$943.0K | $1.1M | -$724.0K | $807.0K | |||||||||||||||||||
| Increase Decrease In Fair Value Of Contingent Consideration Liability | $268.0K | $260.0K | $299.0K | $344.0K | $211.0K | $180.0K | $205.0K | -$636.0K | $273.0K | $215.0K | $208.0K | $201.0K | $856.0K | $694.0K | $129.0K | $120.0K | $116.0K | $112.0K | -$376.0K | $130.0K | $125.0K | -$5.6M | $193.0K | -$848.0K | $197.0K | -$110.0K | $1.1M | $260.0K | $252.0K | $244.0K | $0.00 | $0.00 | $0.00 | ||||||||||||
| Proceeds From Issuance Of Common Stock | $26.4M | $12.3M | $0.00 | $2.5M | $2.2M | $0.00 | $0.00 | $66.3M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.0K | $142.2M | $0.00 | $56.5M | ||||||||||||||||||||||||||||
| Increase Decrease In Deferred Revenue | -$812.0K | -$244.0K | -$4.1M | $38.8M | $0.00 | -$1.0M | -$6.7M | -$653.0K | $7.4M | -$696.0K | -$213.0K | -$157.0K | $3.0M | $334.0K | -$1.3M | -$806.0K | $455.0K | $12.3M | $462.0K | $861.0K | |||||||||||||||||||||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | $13.3M | $13.3M | $13.3M | $13.0M | $12.7M | $12.6M | $12.3M | $11.9M | $11.5M | $11.5M | $11.1M | $10.8M | $10.5M | $10.1M | $9.8M | $9.4M | $8.9M | $8.5M | $8.1M | $7.6M | $7.1M | $6.6M | $8.6M | $5.6M | $8.6M | $8.1M | $7.4M | $7.1M | $6.4M | $5.9M | $13.3M | $12.1M | $11.5M | $11.1M | $10.5M | $10.2M | $9.9M | $9.9M | $10.4M | $10.1M | $11.5M | $11.9M | $11.8M | ||
| Share Based Compensation | $3.6M | $2.0M | $2.1M | $1.7M | $1.6M | $1.4M | $1.5M | $3.8M | $1.5M | $1.8M | $2.7M | $955.0K | |||||||||||||||||||||||||||||||||
| Effect Of Exchange Rate On Cash And Cash Equivalents | -$361.0K | -$565.0K | $1.3M | $825.0K | $424.0K | -$824.0K | -$51.0K | $3.0M | -$6.0M | $967.0K | -$2.4M | -$611.0K | $1.9M | -$2.5M | $817.0K | -$999.0K | |||||||||||||||||||||||||||||
| Proceeds From Warrant Exercises | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $353.0K | $0.00 | $445.0K | $0.00 | $0.00 | $19.0K | $25.0K | $416.0K | $86.0K | $888.0K | $54.0K | $56.0K | ||||||||||||||||||||||||||||
| Proceeds From Sale Of Property Plant And Equipment | $0.00 | $0.00 | $2.0K | $9.0K | $25.0K | $2.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.0K | -$13.0K | $4.0K | $0.00 | -$44.0K | -$10.0K | -$24.0K | $57.0K | $38.0K | $131.0K | -$361.0K | -$565.0K | $1.3M | ||||||||||||||||||||||||||||||||
| Payments For Proceeds From Investments | $24.4M | $0.00 | $0.00 | $334.0K | $0.00 | $0.00 | $75.4M | -$5.8M | -$1.7M | -$26.6M | $712.0K | $84.4M | $13.3M | $17.1M | $9.9M | -$37.4M | $291.0K | $43.0M | |||||||||||||||||||||||||||
| Increase Decrease In Other Operating Liabilities | -$104.0K | -$72.0K | -$74.0K | -$75.0K | -$116.0K | -$131.0K | -$446.0K | -$8.0K | -$87.0K | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||
| Increase Decrease In Income Taxes Receivable | -$98.0K | $0.00 | $0.00 | $2.0K | $0.00 | -$294.0K | $15.0K | $0.00 | -$98.0K | $0.00 | $0.00 | $0.00 | -$10.0K | ||||||||||||||||||||||||||||||||
| Proceeds From Income Tax Refunds | $0.00 | $0.00 | $108.0K | $108.0K | $0.00 | $0.00 | $0.00 | $25.0K | $0.00 | $10.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.17 | -$0.38 | -$0.44 | -$0.46 | -$0.83 | -$1.00 | -$2.89 | -$1.21 | -$1.56 | -$7.24 | -$1.38 | -$1.80 | -$0.92 | $2.07 | -$0.89 | -$1.20 | -$0.85 |
| Common Stock Shares Outstanding | 192.5M | 190.0M | 169.9M | 157.5M | 145.0M | 89.7M | 64.8M | 55.5M | 55.1M | 54.8M | 54.6M | 22.4M | 19.0M | 14.3M | 12.1M | 10.3M | |
| Common Stock Shares Issued | 192.5M | 190.0M | 169.9M | 157.5M | 145.0M | 89.7M | 64.8M | 55.5M | 55.1M | 54.8M | 54.6M | 22.4M | 19.0M | 14.3M | 12.1M | 10.3M | |
| Earnings Per Share Basic | $-0.17 | $-0.38 | $-0.44 | $-0.46 | $-0.83 | $-1.00 | $-1.21 | $-1.56 | $-7.24 | $-1.38 | $-1.80 | $-0.92 | $2.16 | $-0.89 | $-1.20 | ||
| Weighted Average Number Of Shares Outstanding Basic | 191.6M | 185.6M | 166.0M | 150.9M | 106.2M | 75.8M | 55.3M | 54.7M | 53.1M | 45.5M | 21.6M | 15.3M | 13.7M | 11.3M | 10.3M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 191.6M | 185.6M | 166.0M | 150.9M | 106.2M | 75.8M | 55.3M | 54.7M | 53.1M | 45.5M | 21.6M | 15.3M | 14.3M | 11.3M | 10.3M | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 75.8M | 57.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.04 | $0.01 | -$0.13 | -$0.10 | -$0.11 | -$0.10 | -$0.12 | -$0.10 | -$0.10 | -$0.12 | -$0.10 | -$0.11 | -$0.24 | -$0.23 | -$0.21 | -$0.27 | -$0.25 | -$0.25 | -$1.50 | -$0.46 | -$0.47 | -$0.38 | -$0.49 | $0.01 | -$0.36 | -$0.21 | -$0.33 | -$0.34 | -$0.37 | -$2.47 | -$0.31 | -$0.57 | -$0.27 | -$0.40 | -$0.39 | -$0.28 | -$0.91 | -$0.41 | -$0.21 | -$0.18 |
| Common Stock Shares Outstanding | 192.0M | 191.6M | 191.5M | 189.4M | 188.7M | 180.2M | 167.7M | 166.9M | 165.1M | 152.7M | 148.8M | 148.7M | 110.3M | 97.7M | 96.2M | 84.6M | 71.3M | 56.9M | 56.9M | 56.9M | 56.3M | 55.5M | 55.3M | 55.1M | 55.1M | 55.0M | 55.0M | 54.8M | 54.8M | 54.6M | 54.6M | 54.3M | 54.1M | 22.3M | 22.1M | 22.0M | ||||
| Common Stock Shares Issued | 192.0M | 191.6M | 191.5M | 189.4M | 188.7M | 180.2M | 167.7M | 166.9M | 165.1M | 152.7M | 148.8M | 148.7M | 110.3M | 97.7M | 96.2M | 84.6M | 71.3M | 56.9M | 56.9M | 56.9M | 56.3M | 55.5M | 55.3M | 55.1M | 55.1M | 55.0M | 55.0M | 54.8M | 54.8M | 54.6M | 54.6M | 54.3M | 54.1M | 22.3M | 22.1M | 22.0M | ||||
| Earnings Per Share Basic | $-0.04 | $0.01 | $-0.13 | $-0.10 | $-0.11 | $-0.10 | $-0.12 | $-0.10 | $-0.10 | $-0.12 | $-0.10 | $-0.11 | $-0.24 | $-0.23 | $-0.21 | $-0.27 | $-0.25 | $-0.25 | $-0.46 | $-0.38 | $-0.49 | $0.01 | $-0.36 | $-0.33 | $-0.40 | $-0.91 | ||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 191.8M | 191.6M | 190.7M | 189.0M | 188.0M | 175.6M | 167.5M | 166.1M | 161.6M | 151.0M | 148.8M | 148.4M | 101.3M | 96.9M | 93.4M | 79.5M | 69.6M | 67.7M | 56.8M | 55.2M | 54.6M | 30.2M | 19.8M | |||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 191.8M | 192.4M | 190.7M | 189.0M | 188.0M | 175.6M | 167.5M | 166.1M | 161.6M | 151.0M | 148.8M | 148.4M | 101.3M | 96.9M | 93.4M | 79.5M | 69.6M | 67.7M | 56.8M | 56.5M | 54.6M | |||||||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 79.5M | 69.6M | 67.7M | 56.9M | 56.8M | 55.7M | 55.4M | 55.1M | 54.9M | 54.6M | 54.3M | 53.7M | 52.7M | 51.4M | 50.8M | 54.3M | 30.2M | 22.2M | 22.1M | 19.8M | 14.5M | 14.4M | 14.3M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $4.1M | $6.6M | $5.7M | $2.2M | $127.0K | $741.0K | $2.1M | $3.0M | $1.5M | $1.4M | $674.0K | $853.0K | $540.0K | $138.0K | $126.3K | $107.0K | $163.7K |
| Foreign Currency Transaction Gain Loss Before Tax | $14.0K | -$49.0K | $25.0K | -$22.0K | $5.0K | -$124.0K | $41.0K | -$1.0M | $2.3M | $1.1M | $21.8M | $4.1M | $1.1M | $25.0K | -$14.7K | -$7.1K | -$435.7K |
| Stock Issued During Period Value Stock Options Exercised | $5.5M | $7.5M | $260.0K | $122.0K | $2.1M | $449.0K | $307.0K | $1.4M | $213.0K | $258.0K | $1.7M | $2.6M | $389.0K | $71.0K | $10.8K | $34.9K | $7.9K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $7.0M | $9.0M | $9.3M | $7.2M | $6.4M | $6.1M | $7.2M | $6.7M | $14.9M | $38.2M | $22.1M | $3.3M | $903.0K | $982.0K | |||
| Depreciation | $363.0K | $1.4M | $1.4M | $1.4M | $1.8M | $2.0M | $2.0M | $2.2M | $2.0M | $1.1M | $589.0K | $529.0K | $613.0K | $866.0K | $986.9K | $1.0M | $988.7K |
| Additional Paid In Capital | $83.3M | $82.0M | $81.3M | $72.4M | $65.5M | $60.8M | $55.2M | $48.1M | $42.8M | $36.5M | $30.2M | $26.2M | $25.3M | $24.8M | $30.7M | $30.2M | |
| Foreign Currency Transaction Gain Loss Unrealized | $5.0K | $56.0K | $68.0K | -$1.0M | $2.4M | $1.0M | $22.0M | $4.2M | $18.0K | -$29.3K | $20.3K | ||||||
| Stock Issued During Period Value New Issues | $134.7M | $86.3M | $18.6M | $66.3M | $48.9M | $142.2M | $56.5M | $32.0M | $3.0M | $3.9M | |||||||
| Fair Value Option Changes In Fair Value Gain Loss1 | $0.00 | -$22.0K | $530.0K | $3.3M | -$10.4M | -$3.5M | -$3.8M | $579.5K | |||||||||
| Warrants And Rights Outstanding | $107.0K | $883.0K | $5.1M | $5.4M | $4.0M | $205.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $952.0K | $1.0M | $1.2M | $1.7M | $1.8M | $1.5M | $1.5M | $1.5M | $1.3M | $694.0K | $396.0K | $159.0K | $27.0K | $31.0K | $39.0K | $100.0K | $200.0K | $345.0K | $503.0K | $606.0K | $600.0K | $756.0K | $805.0K | $758.0K | $337.0K | $390.0K | $368.0K | $425.0K | $435.0K | $244.0K | $183.0K | $81.0K | $202.0K | $304.0K | $257.0K | $147.0K | $129.0K | $146.0K | $145.0K | |
| Foreign Currency Transaction Gain Loss Before Tax | -$12.0K | $21.0K | $4.0K | $5.0K | -$8.0K | -$13.0K | $6.0K | $1.0K | $4.0K | -$21.0K | $3.0K | $0.00 | -$15.0K | -$13.0K | $28.0K | -$19.0K | -$47.0K | -$18.0K | -$25.0K | $60.0K | $8.0K | $145.0K | -$359.0K | -$526.0K | $1.2M | $798.0K | $427.0K | -$795.0K | $33.0K | $2.9M | $11.8M | -$2.6M | $7.0M | $3.1M | -$2.7M | $1.4M | $52.0K | -$61.0K | -$5.0K | |
| Stock Issued During Period Value Stock Options Exercised | $794.0K | $453.0K | $2.7M | $185.0K | $2.0M | $2.5M | $259.0K | $113.0K | $8.0K | $2.0M | $15.0K | $208.0K | $336.0K | -$86.0K | $166.0K | $2.0K | $288.0K | $434.0K | $735.0K | $103.0K | $1.0K | $115.0K | $620.0K | $1.9M | ||||||||||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.3M | $864.0K | $3.6M | $2.2M | $3.2M | $2.0M | $2.5M | $3.0M | $2.1M | $1.7M | $2.1M | $1.7M | $1.5M | $1.8M | $1.6M | $1.7M | $1.6M | $1.5M | $1.6M | $3.9M | $1.7M | $1.7M | $1.9M | $1.5M | $4.4M | $7.9M | $2.9M | |||||||||||||
| Depreciation | $447.0K | $436.0K | $443.0K | $490.0K | $501.0K | $500.0K | $507.0K | $505.0K | $509.0K | $497.0K | $578.0K | $602.0K | $593.0K | $480.0K | $334.0K | $291.0K | $252.0K | $217.0K | $153.0K | $147.0K | $120.0K | $133.0K | $149.0K | $134.0K | $148.0K | $148.0K | $166.0K | |||||||||||||
| Additional Paid In Capital | $83.3M | $82.6M | $82.1M | $81.4M | $81.8M | $80.2M | $79.5M | $77.2M | $74.2M | $70.7M | $69.1M | $67.2M | $64.1M | $63.9M | $62.1M | $59.6M | $58.3M | $56.8M | $55.4M | $53.7M | $49.6M | $45.5M | $44.4M | $43.8M | $40.8M | $39.8M | $37.8M | $34.5M | $32.8M | $30.2M | $28.5M | $27.8M | $28.6M | $25.9M | $25.7M | $24.8M | ||||
| Foreign Currency Transaction Gain Loss Unrealized | $0.00 | -$44.0K | -$10.0K | -$24.0K | $57.0K | $38.0K | $131.0K | -$361.0K | -$565.0K | $1.3M | $824.0K | $425.0K | -$826.0K | -$51.0K | $3.0M | $11.8M | -$2.6M | $7.1M | $3.2M | -$1.4M | $59.0K | -$15.0K | -$6.0K | |||||||||||||||||
| Stock Issued During Period Value New Issues | $9.0M | $44.7M | $4.3M | $26.4M | $48.8M | $5.0M | $12.3M | $2.5M | $2.2M | $0.00 | $66.3M | $142.2M | $56.5M | |||||||||||||||||||||||||||
| Fair Value Option Changes In Fair Value Gain Loss1 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$22.0K | $10.0K | $168.0K | $161.0K | $2.0M | $2.0M | -$1.2M | -$5.1M | $5.8M | -$13.6M | -$2.4M | -$2.4M | $308.0K | ||||||||||||||||||||||
| Warrants And Rights Outstanding | $770.0K | $1.1M | $1.0M | $0.00 | $0.00 | $0.00 | $0.00 | $297.0K | $308.0K | $722.0K | $1.5M | $3.6M | $5.6M | $8.7M | $6.6M | $12.8M |
Most recent annual filing with the SEC: March 23, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.